The eye drops for dry eye syndrome developed by Baiyun Mountain Pharmaceutical in Guangzhou have been approved to conduct clinical trials.

According to the news from Guangdong Yao Baiyunshan's official WeChat account, recently, Guangzhou Baiyunshan Zhongyi Pharmaceutical's exclusive core productZhangyanming tablets has officially received the "Clinical Trial Approval Notice" issued by the National Medical Products Administration, approving the commencement of clinical trials for the new indication of "dry eye."